SCHEMBL491524

SCHEMBL491524

CCC(Cc1ccccc1)C(=O)O

nearest known ligand 0.83

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.83
PPARG P37231 3/20 0.67
CPA1 P15085 7/20 0.66
CPA3 P15088 3/20 0.66
FOLH1 Q04609 3/20 0.66
CPB1 P15086 1/20 0.66
CPB2 Q96IY4 1/20 0.66
SLC1A3 P43003 1/20 0.59
SLC1A2 P43004 1/20 0.59
SLC1A1 P43005 1/20 0.59
PPARD Q03181 1/20 0.57
PPARA Q07869 1/20 0.57
MME P08473 1/20 0.56
NAALAD2 Q9Y3Q0 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL265514 1.00 CYP1A2 (0.83) CYP1A2PPARGCPA1CPA3FOLH1
SCHEMBL265063 1.00 CYP1A2 (0.83) CYP1A2PPARGCPA1CPA3FOLH1
SCHEMBL4664822 0.91 CYP1A2 (1.00) CYP1A2CPA1CPA3FOLH1CPB1
SCHEMBL12493651 0.90 CYP1A2 (0.74) CYP1A2PPARGCPA1CPA3FOLH1
SCHEMBL22115491 0.89 CYP1A2 (0.95) CYP1A2CPA1CPA3FOLH1CPB1
SCHEMBL27291058 0.89 CYP1A2 (0.95) CYP1A2CPA1CPA3FOLH1CPB1
SCHEMBL9875948 0.89 CYP1A2 (0.95) CYP1A2CPA1CPA3FOLH1CPB1
SCHEMBL4886609 0.88 CYP1A2 (0.69) CYP1A2PPARGCPA1CPA3FOLH1
SCHEMBL21895912 0.86 CYP1A2 (0.67) CYP1A2PPARGCPA1CPA3FOLH1
SCHEMBL11634382 0.86 CYP1A2 (0.67) CYP1A2PPARGCPA1CPA3FOLH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 332 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115290793-B Method for judging storage time of semi-fermented type fermented bean curd 上海应用技术大学 2025-03-21 CN claimed
EP-4255208-B1 CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS VOYAGE FOODS INC (US) 2024-12-25 EP claimed
EP-3930472-B1 COFFEE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS VOYAGE FOODS INC (US) 2024-09-11 EP claimed
CN-115290793-A Method for judging storage time of semi-fermented strong-smelling preserved bean curd 上海应用技术大学 2022-11-04 CN claimed
CN-113504378-B Olfactory receptor, recombinant cell, kit and use thereof 汉王科技股份有限公司 2022-01-04 CN claimed
CN-113504378-A Olfactory receptor, recombinant cell, kit and use thereof 汉王科技股份有限公司 2021-10-15 CN claimed
EP-3387099-B1 FOOD CONTACT SURFACE SANITIZING LIQUID CLOROX CO (US) 2021-07-21 EP claimed
US-20200040108-A1 PROCESS FOR MAKING A CONSUMER PRODUCT COMPRISING MODIFIED POLYSACCHARIDES PROCTER & GAMBLE INTERNATIONAL OPERATIONS SA 2020-02-06 US claimed
WO-2020026143-A1 PROCESS FOR MAKING A CONSUMER PRODUCT COMPRISING MODIFIED POLYSACCHARIDES PROCTER & GAMBLE INTERNATIONAL OPERATIONS SA (CH) 2020-02-06 WO claimed
EP-3604346-A1 PROCESS FOR MAKING A CONSUMER PRODUCT COMPRISING MODIFIED POLYSACCHARIDES Procter & Gamble International Operations SA (CH) 2020-02-05 EP claimed
US-20040197932-A1 Bio-vehicle, biosensor and biotransducer system EXON SCIENCE, INC. (TW) 2004-10-07 US claimed
EP-0888441-B1 PROCESS OF MANUFACTURING OF BUILT AUTOMATIC DISHWASHING COMPOSITIONS COMPRISING BLOOMING PERFUME PROCTER & GAMBLE (US) 2004-10-06 EP claimed
EP-0888446-B1 TOILET BOWL DETERGENT SYSTEM CONTAINING BLOOMING PERFUME PROCTER & GAMBLE (US) 2003-10-15 EP claimed
EP-0888440-B1 GLASS CLEANING COMPOSITIONS CONTAINING BLOOMING PERFUME PROCTER & GAMBLE (US) 2003-01-29 EP claimed
US-6403646-B1 ADMINISTERING PHENYLBUTYRIC ACID OR DERIVATIVES TO TREAT LIVER DISEASE AND EMPHYSEMA CAUSED BY PROTEASE INHIBITOR TYPE Z MUTATION; STIMULATES SECRETION WITHOUT INCREASING SYNTHESIS OF PROTEIN PERLMUTTER DAVID H (US) 2002-06-11 US claimed
US-6210816-B1 Translucent xerographic recording substrates XEROX CORPORATION 2001-04-03 US claimed
EP-0812538-B1 Preservative compositions ANGUS CHEMICAL (US) 2001-01-03 EP claimed
EP-0889877-A1 META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS G.D. SEARLE & CO. (US) 1999-01-13 EP claimed
WO-1997036862-A1 META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS G.D. SEARLE & CO. (US) 1997-10-09 WO claimed
EP-0066864-B1 NEW CHEWING GUM BASE AND THEIR USE IN A CHEWING GUM NABISCO BRANDS, Inc. (US) 1986-03-05 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200040108-A1 PROCESS FOR MAKING A CONSUMER PRODUCT COMPRISING MODIFIED POLYSACCHARIDES MGAM, FUT5, FUT6 CYP1A2 501/4885PPARG 1181/4885CPA1 2073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.